FDA


Home \| Tell a Friend About Us! \| Contact Us \| Search \| MEMBER LOGIN

Tell a Friend About Us!

About this Site

Sample Articles

Subscribe Today

Who We Are

Affiliate Program

Got a Product / Service?

Need a Speaker?

Here's what our members are saying about us...

"In late February, the local CBS affiliate ran a 3 minute "public interest" (?) story on 2 women that feel they were injured by a chiropractic adjustment. While my patients trust me and what I do to be safe, like most chiropractic patients, they needed help talking to friends and family members about the safety and effectiveness of their choice to continue getting adjusted.

Less than 2 weeks after the TV story, the In Touch Newsletter arrived at my door with its lead article being a review of the Spine article showing no statistical connection between chiropractic adjustments and stroke. I loved it. It is displayed prominently in my office."

Dr. Tim Knight
Arlington, MA

"Voice For Health is so well received - patients ask for them. It is a wonderful publication, entertaining and informative in the right kind of language."

Dr. Gerald Arndt
Coshocton, OH

"Thanks for your commitment to the cause and your great Voice For Health publication over the years."

Dr. Robson Timbs
Malvern, South Australia

"Continuous patient education is a MUST. The problem is, how do you do this and keep it fresh, interesting, and informative all at the same time? That’s where Dr. Kim Stetzel’s WEEKLY HANDOUTS Program comes in! She’s done the work. She’s created interesting and informative, full color handouts. All you have to do is put them in your patient’s hands and let the handouts speak for themselves! I highly recommend this program for anyone who is interested in growing and maintaining a Lifetime Family Wellness practice."

Dr. George Auger
Greenville, SC

"What a great program. With our busy schedule, we didn’t always get time to put out regular patient education. Now, we just print out quality, full color, professional looking handouts on our color printer each week. WOW! thanks for taking the work out of consistent patient education."

Drs. Kevorkian & Giuliano
Westwood, MA

Welcome to the FDA Article Archive of In Touch Education Services' Health Care Research Center.

Simply click on any of the headlines below to read the article. If you'd like to print the article, be sure to click on the "Printer-Friendly Format" icon before you print.

Thank you for sharing this information with your friends and family!

Influenza Drug Tamiflu's Effectiveness Questioned
A January 17, 2012 review of the influenza drug Tamiflu by the Cochrane Database of Systematic Reviews has raised questions about the effectiveness of the medication. Questions al . . . keep reading

FDA Renews Warning On Acetaminophen
A December 22, 2011 warning from the U.S. Food and Drug Administration (FDA) says that 2009 guidelines for infant doses of acetaminophen may actually increase the possibilities of . . . keep reading

FDA Downplayed Stop-Smoking Drug Chantix Suicide Risk
A November 3, 2011 report in the online edition of PLoS ONE, says that by focusing only on episodes of depression and suicidality that ended in hospitalization, a recent FDA revie . . . keep reading

FDA: Antipsychotic Drug Causes Severe Allergic Reactions
On September 1, 2011, the U.S. Food and Drug Administration (FDA) published a warning that the antipsychotic drug Saphris can cause life-threatening allergic reactions, even at th . . . keep reading

FDA Warns Anti-Nausea Drug May Trigger Heart Arrhythmias
A September 15, 2011 warning from the U.S. Food and Drug Administration (FDA) says a drug used to treat nausea and vomiting may trigger dangerous and possibly lethal changes in he . . . keep reading

FDA Issues Warning On Antipsychotic Drug Saphris
On September 1, 2011, the U.S. Food and Drug Administration (FDA) issued a warning that the antipsychotic drug Saphris can cause life-threatening allergic reactions, sometimes as . . . keep reading

Drug Ads Ignore FDA Regulations
The August 22, 2011 online edition of Public Library of Science One reports on a study that found most advertisements for drugs are not in compliance with FDA regulations. &n . . . keep reading

FDA Warns Of Bladder Cancer Risk With Diabetes Drug Actos
On June 15, 2011, the U.S. Food and Drug Administration (FDA) issued a warning that patients taking the diabetes drug Actos for more than a year may run an increased risk of devel . . . keep reading

FDA Warns Of Myocardial Infarction and Circulatory Risk With Chantix
On June 16, 2011, the U.S. Food and Drug Administration (FDA) announced label changes to the stop-smoking drug Chantix and issued a warning that smokers with a history of heart a . . . keep reading

FDA Recommends Limited Use Of Anesthesia In Kids
On March 10, 2011, a U.S. Food and Drug Administration (FDA) advisory panel has recommended that the use of anesthesia in young children should be limited because children exposed . . . keep reading

FDA Orders New Danger Labels For Antipsychotic Drugs
In a February 22, 2011 announcement, the U.S. Food and Drug Administration (FDA) has ordered that all antipsychotic drugs must contain new label information regarding the dangers . . . keep reading

FDA Limits Amount Of Acetaminophen In Combination Pain Medications
On January 13, 2011, the US Food and Drug Administration (FDA) issued an order restricting the amount of acetaminophen that could be used in combination pain medications due to t . . . keep reading

FDA Issues Warning On Cough Drug After Child Deaths
On December 14, 2010, the U.S. Food and Drug Administration (FDA) issued new label warnings for the prescription cough medication Tessalon (generic name benzonatate) after reviewi . . . keep reading

FDA Device Oversight Found Lacking
The November 2, 2010 online edition of the British Medical Journal features an article by journalists Jeanne Lenzer and Shannon Brownlee charging the U.S. Food and Drug Administra . . . keep reading

Drug Maker Pulls Diet Drug Meridia From Market
On October 8, 2010 the U.S. Food and Drug Administration (FDA) announced that drug maker Abbot has agreed to remove the diet drug Meridia (generic name sibutramine) from the U.S. . . . keep reading

FDA Sets New Rules For Reporting Adverse Trial Events
On September 29, 2010 the U.S. Food and Drug Administration (FDA) announced they have finalized new procedures they claim will speed up reporting and analysis of potential safety . . . keep reading

More Headlines

Top Ten In Touch Wellness Articles
Top Ten Voice For Health Articles
Top Five Weekly Handouts
Monthly Articles

All Products

Disclaimer

Operational Guidelines

Our Guarantee

Twitter